Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S has launched a share repurchase program on August 7, 2024, as part of a larger DKK 20 billion buy-back plan set to occur over 12 months starting February 6, 2024. The company aims to repurchase up to DKK 2.4 billion worth of B shares by November 4, 2024. As of August 9, 2024, Novo Nordisk has bought back 11,197,376 B shares at an average price of DKK 878.79 each, reaching a total spend of DKK 9,840,107,327.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
